Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin in acute ischemic stroke
2014-003123-22Phase 2Completed
- Sponsor
- José Castillo Sanchez
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Flavin mononucleotide in ischemic stroke (2 arms), sponsored by José Castillo Sanchez. Primary endpoint: Change in serum glutamate concentration. Started Nov 2014; status: completed.
02
Drugs
Flavin mononucleotide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2014-003123-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003123-22.